This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Pectus carinatum
Q17_PECTUS_CARINATUM
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
51 |
4. Check minimum number of eventsNone |
51 |
5. Include endpointsNone |
51 |
6. Filter based on genotype QC (FinnGen only) |
48 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Similar endpoints
↥List of similar endpoints to
Pectus carinatum
based on the number of shared cases.
Similar with more cases:
- Congenital musculoskeletal deformities of head, face, spine and chest
- Congenital malformations and deformations of the musculoskeletal system
- Congenital malformations and deformations of the musculoskeletal system
- Congenital malformations, deformations and chromosomal abnormalities
- Congenital malformations, deformations and chromosomal abnormalities
Similar with less cases:
None
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: unknown.
No upset table: unknown.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 48 | 15 | 33 |
| Unadjusted period prevalence (%) | 0.01 | 0.01 | 0.02 |
| Median age at first event (years) | 14.96 | 14.70 | 15.08 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 51
- Matched controls
- 510
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Q677, ,
ICD-10 Finland
Pectus carinatum
+∞
73.0
51
*
J01CA04, ,
ATC
amoxicillin; systemic
+∞
67.9
49
*
A98, ,
ICD-O-3
+∞
65.6
48
*
SAA01, ,
ICD-O-3
+∞
54.1
42
*
SAA02, ,
ICD-O-3
+∞
52.4
41
*
M01AE01, ,
ATC
ibuprofen; systemic, rectal
+∞
52.4
41
*
WX110, ,
ICD-O-3
+∞
50.8
40
*
J01CE02, ,
ATC
phenoxymethylpenicillin; oral
+∞
50.8
40
*
N02BE01, ,
ATC
paracetamol; systemic, rectal
+∞
47.5
38
*
J01DB01, ,
ATC
cefalexin; oral
+∞
44.4
36
*
K021, ,
ICD-O-3
+∞
44.4
36
*
SFA10, ,
ICD-O-3
+∞
39.9
33
*
WX290, ,
ICD-O-3
+∞
38.5
32
*
-1, ,
ICD-O-3
+∞
38.5
32
*
M01AE02, ,
ATC
naproxen; oral, rectal
+∞
38.5
32
*
J01FA10, ,
ATC
azithromycin; systemic
+∞
38.5
32
*
J069, ,
ICD-O-3
+∞
37.0
31
*
SAA03, ,
ICD-O-3
+∞
34.3
29
*
EB1SA, ,
ICD-O-3
+∞
32.9
28
*
EB1HA, ,
ICD-O-3
+∞
31.5
27
*
J01CR02, ,
ATC
amoxicillin and beta-lactamase inhibitor; systemic
+∞
30.2
26
*
SFA20, ,
ICD-O-3
+∞
30.2
26
*
KMAK, ,
ICD-O-3
+∞
28.9
25
*
WZB00, ,
ICD-O-3
+∞
28.9
25
*
SCA01, ,
ICD-O-3
+∞
27.6
24
*
EB1AA, ,
ICD-O-3
+∞
27.6
24
*
WZC00, ,
ICD-O-3
+∞
26.3
23
*
GD1AA, ,
ICD-O-3
+∞
26.3
23
*
R83, ,
ICD-O-3
+∞
25.1
22
*
R74, ,
ICD-O-3
+∞
25.1
22
*
OAB43, ,
ICD-O-3
+∞
23.8
21
*
J01DA01, ,
ATC
[U] cefalexin
+∞
23.8
21
*
R03AC02, ,
ATC
salbutamol; inhalant
+∞
23.8
21
*
EBA00, ,
ICD-O-3
+∞
22.6
20
*
Z012, ,
ICD-O-3
+∞
22.6
20
*
SDA03, ,
ICD-O-3
+∞
22.6
20
*
J01AA02, ,
ATC
doxycycline; systemic
+∞
22.6
20
*
R06AE07, ,
ATC
cetirizine; oral
+∞
22.6
20
*
SPAT1263, ,
ICD-O-3
+∞
22.6
20
*
R01AD09, ,
ATC
mometasone; nasal
+∞
21.3
19
*
WYA05, ,
ICD-O-3
+∞
21.3
19
*
R21, ,
ICD-O-3
+∞
20.1
18
*
M03BX02, ,
ATC
tizanidine; oral
+∞
20.1
18
*
ZXE00, ,
ICD-O-3
+∞
20.1
18
*
S18, ,
ICD-O-3
+∞
20.1
18
*
J01EE02, ,
ATC
sulfadiazine and trimethoprim; systemic
+∞
18.9
17
*
VALMI, ,
ICD-O-3
+∞
18.9
17
*
E0000UV, ,
ATC
+∞
18.9
17
*
ZXE10, ,
ICD-O-3
+∞
18.9
17
*
K0364, ,
ICD-O-3
+∞
17.7
16
*
J01DA08, ,
ATC
[U] cefaclor
+∞
17.7
16
*
D82, ,
ICD-O-3
+∞
17.7
16
*
R104, ,
ICD-10 Finland
Other and unspecified abdominal pain
+∞
17.7
16
*
Z3231, ,
ICD-O-3
+∞
17.7
16
*
SDE02, ,
ICD-O-3
+∞
16.5
15
*
R05, ,
ICD-O-3
+∞
16.5
15
*
R06AX27, ,
ATC
desloratadine; oral
+∞
16.5
15
*
ZXD10, ,
ICD-O-3
+∞
16.5
15
*
S01GX01, ,
ATC
cromoglicic acid; ophthalmic
+∞
16.5
15
*
SDA02, ,
ICD-O-3
+∞
15.4
14
*
SPAT1310, ,
ICD-O-3
+∞
15.4
14
*
SPAT1249, ,
ICD-O-3
+∞
15.4
14
*
SFA30, ,
ICD-O-3
+∞
15.4
14
*
EBA10, ,
ICD-O-3
+∞
15.4
14
*
N02AJ06, ,
ATC
codeine and paracetamol; systemic
+∞
15.4
14
*
SPAT1315, ,
ICD-O-3
+∞
14.2
13
*
A02BC02, ,
ATC
pantoprazole; systemic
+∞
14.2
13
*
H02AB06, ,
ATC
prednisolone; systemic
+∞
14.2
13
*
S01XA20, ,
ATC
artificial tears and other indifferent preparations; ophthalmic
+∞
14.2
13
*
M01AH05, ,
ATC
etoricoxib; oral
+∞
14.2
13
*
SDA01, ,
ICD-O-3
+∞
14.2
13
*
SPAT1363, ,
ICD-O-3
+∞
14.2
13
*
K0532, ,
ICD-O-3
+∞
14.2
13
*
SPAT1253, ,
ICD-O-3
+∞
14.2
13
*
WZA90, ,
ICD-O-3
+∞
13.1
12
*
U071, ,
ICD-O-3
+∞
13.1
12
*
J01FA06, ,
ATC
roxithromycin; oral
+∞
13.1
12
*
J01FA09, ,
ATC
clarithromycin; systemic
+∞
13.1
12
*
R01BA51, ,
ATC
phenylpropanolamine, combinations; oral
+∞
13.1
12
*
P01, ,
ICD-O-3
+∞
13.1
12
*
SAB02, ,
ICD-O-3
+∞
13.1
12
*
J01DA09, ,
ATC
[U] cefadroxil
+∞
13.1
12
*
OAA65, ,
ICD-O-3
+∞
13.1
12
*
SPAT1312, ,
ICD-O-3
+∞
11.9
11
*
J01MA02, ,
ATC
ciprofloxacin; systemic
+∞
11.9
11
*
WX402, ,
ICD-O-3
+∞
11.9
11
*
R01AD12, ,
ATC
fluticasone furoate; nasal
+∞
11.9
11
*
SPAT1283, ,
ICD-O-3
+∞
11.9
11
*
R01AD08, ,
ATC
fluticasone; nasal
+∞
11.9
11
*
X58, ,
ICD-10 Finland
Exposure to other specified factors
+∞
11.9
11
*
SPAT1301, ,
ICD-O-3
+∞
11.9
11
*
N02AX02, ,
ATC
tramadol; systemic, rectal
+∞
11.9
11
*
N05AH04, ,
ATC
quetiapine; oral
+∞
11.9
11
*
SBB10, ,
ICD-O-3
+∞
11.9
11
*
K020, ,
ICD-O-3
+∞
11.9
11
*
OAB48, ,
ICD-O-3
+∞
11.9
11
*
R05FA02, ,
ATC
opium derivatives and expectorants; systemic
+∞
11.9
11
*
ZXD05, ,
ICD-O-3
+∞
11.9
11
*
SCA02, ,
ICD-O-3
+∞
11.9
11
*
A03, ,
ICD-O-3
+∞
11.9
11
*
R01AD58, ,
ATC
fluticasone, combinations; nasal
+∞
10.8
10
*
U072, ,
ICD-O-3
+∞
10.8
10
*
L03, ,
ICD-O-3
+∞
10.8
10
*
Z871, ,
ICD-O-3
+∞
10.8
10
*
SAB01, ,
ICD-O-3
+∞
10.8
10
*
Z018, ,
ICD-10 Finland
Other specified special examinations
+∞
10.8
10
*
D19, ,
ICD-O-3
+∞
10.8
10
*
L12, ,
ICD-O-3
+∞
10.8
10
*
M01AB05, ,
ATC
diclofenac; systemic, rectal
+∞
10.8
10
*
N02AA59, ,
ATC
codeine, combinations excl. psycholeptics; systemic
+∞
10.8
10
*
Q676, ,
ICD-10 Finland
Pectus excavatum
+∞
10.8
10
*
C07AA05, ,
ATC
propranolol; systemic
+∞
10.8
10
*
FM1EE, ,
ICD-O-3
+∞
10.8
10
*
R4110, ,
ICD-O-3
+∞
10.8
10
*
SPAT1321, ,
ICD-O-3
+∞
10.8
10
*
Z010, ,
ICD-10 Finland
Examination of eyes and vision
+∞
9.7
9
*
Z718, ,
ICD-10 Finland
Other specified counselling
+∞
9.7
9
*
P01AB01, ,
ATC
metronidazole; oral, rectal
+∞
9.7
9
*
WX408, ,
ICD-O-3
+∞
9.7
9
*
SFC01, ,
ICD-O-3
+∞
9.7
9
*
A02BC01, ,
ATC
omeprazole; systemic
+∞
9.7
9
*
SPAT1256, ,
ICD-O-3
+∞
9.7
9
*
N06AX11, ,
ATC
mirtazapine; oral
+∞
9.7
9
*
JN3AE, ,
ICD-O-3
+∞
9.7
9
*
HMAK, ,
ICD-O-3
+∞
9.7
9
*
SPAT1325, ,
ICD-O-3
+∞
9.7
9
*
F510, ,
ICD-O-3
+∞
9.7
9
*
R2130, ,
ICD-O-3
+∞
9.7
9
*
DCA20, ,
ICD-O-3
+∞
9.7
9
*
R05DA20, ,
ATC
opium alkaloids and derivatives - combinations
+∞
9.7
9
*
WYA50, ,
ICD-O-3
+∞
9.7
9
*
N06AB10, ,
ATC
escitalopram; oral
+∞
9.7
9
*
Z712, ,
ICD-O-3
+∞
9.7
9
*
R074, ,
ICD-10 Finland
Chest pain, unspecified
+∞
8.6
8
*
R06AE09, ,
ATC
levocetirizine; oral
+∞
8.6
8
*
SPAT1308, ,
ICD-O-3
+∞
8.6
8
*
SCE00, ,
ICD-O-3
+∞
8.6
8
*
L17, ,
ICD-O-3
+∞
8.6
8
*
SFA00, ,
ICD-O-3
+∞
8.6
8
*
SPAT1223, ,
ICD-O-3
+∞
8.6
8
*
UJD10, ,
ICD-O-3
+∞
8.6
8
*
J010, ,
ICD-O-3
+∞
8.6
8
*
Z2221, ,
ICD-O-3
+∞
8.6
8
*
N06AB06, ,
ATC
sertraline; oral
+∞
8.6
8
*
K045, ,
ICD-O-3
+∞
8.6
8
*
A12AX, ,
ATC
Calcium, combinations with vitamin D and/or other drugs
+∞
8.6
8
*
SJX10, ,
ICD-O-3
+∞
8.6
8
*
J01CA08, ,
ATC
pivmecillinam; oral
+∞
8.6
8
*
GD1UA, ,
ICD-O-3
+∞
8.6
8
*
SXC05, ,
ICD-O-3
+∞
8.6
8
*
L15, ,
ICD-O-3
+∞
8.6
8
*
OAA67, ,
ICD-O-3
+∞
8.6
8
*
H01, ,
ICD-O-3
+∞
8.6
8
*
N05BA04, ,
ATC
oxazepam; oral
+∞
8.6
8
*
R03CC02, ,
ATC
salbutamol; systemic
+∞
8.6
8
*
SDA04, ,
ICD-O-3
+∞
8.6
8
*
R103, ,
ICD-10 Finland
Pain localized to other parts of lower abdomen
+∞
8.6
8
*
J01FA01, ,
ATC
erythromycin; systemic
+∞
8.6
8
*
Z004, ,
ICD-10 Finland
General psychiatric examination, not elsewhere classified
+∞
8.6
8
*
OAB42, ,
ICD-O-3
+∞
8.6
8
*
SPAT1153, ,
ICD-O-3
+∞
8.6
8
*
S01CA01, ,
ATC
dexamethasone and antiinfectives; ophthalmic
+∞
8.6
8
*
SHB00, ,
ICD-O-3
+∞
7.5
7
*
SPAT1149, ,
ICD-O-3
+∞
7.5
7
*
D07AC13, ,
ATC
mometasone; topical
+∞
7.5
7
*
H13, ,
ICD-O-3
+∞
7.5
7
*
AA1AD, ,
ICD-O-3
+∞
7.5
7
*
J010, ,
ICD-10 Finland
Acute maxillary sinusitis
+∞
7.5
7
*
Z035, ,
ICD-10 Finland
Observation for other suspected cardiovascular diseases
+∞
7.5
7
*
Z760, ,
ICD-O-3
+∞
7.5
7
*
WX105, ,
ICD-O-3
+∞
7.5
7
*
SPAT1240, ,
ICD-O-3
+∞
7.5
7
*
R104, ,
ICD-O-3
+∞
7.5
7
*
Z0389, ,
ICD-10 Finland
Observation for other suspected diseases and conditions
+∞
7.5
7
*
J05AB01, ,
ATC
aciclovir; systemic
+∞
7.5
7
*
D01BA02, ,
ATC
terbinafine; oral
+∞
7.5
7
*
EMB30, ,
ICD-O-3
+∞
7.5
7
*
S29, ,
ICD-O-3
+∞
7.5
7
*
N02CC01, ,
ATC
sumatriptan; nasal, systemic, rectal
+∞
7.5
7
*
J189, ,
ICD-10 Finland
Pneumonia, unspecified
+∞
7.5
7
*
M255, ,
ICD-O-3
+∞
7.5
7
*
F412, ,
ICD-O-3
+∞
7.5
7
*
A04, ,
ICD-O-3
+∞
7.5
7
*
SPAT1316, ,
ICD-O-3
+∞
7.5
7
*
A06AC01, ,
ATC
ispaghula (psylla seeds); oral
+∞
7.5
7
*
D10BA01, ,
ATC
isotretinoin; oral
+∞
7.5
7
*
K0522, ,
ICD-O-3
+∞
7.5
7
*
J069, ,
ICD-10 Finland
Acute upper respiratory infection, unspecified
+∞
7.5
7
*
OAB93, ,
ICD-O-3
+∞
7.5
7
*
E000002, ,
ATC
+∞
7.5
7
*
TPH07, ,
ICD-O-3
+∞
7.5
7
*
L02, ,
ICD-O-3
+∞
7.5
7
*
ZYC01, ,
ICD-O-3
+∞
7.5
7
*
SGA01, ,
ICD-O-3
+∞
7.5
7
*
WX404, ,
ICD-O-3
+∞
7.5
7
*
N01, ,
ICD-O-3
+∞
7.5
7
*
D07AC01, ,
ATC
betamethasone; topical
+∞
7.5
7
*
OAA80, ,
ICD-O-3
+∞
6.4
6
*
EBA05, ,
ICD-O-3
+∞
6.4
6
*
SDE03, ,
ICD-O-3
+∞
6.4
6
*
SBB00, ,
ICD-O-3
+∞
6.4
6
*
ND2AA, ,
ICD-O-3
+∞
6.4
6
*
A084, ,
ICD-10 Finland
Viral intestinal infection, unspecified
+∞
6.4
6
*
R5180, ,
ICD-10 Finland
Headache
+∞
6.4
6
*
P03, ,
ICD-O-3
+∞
6.4
6
*
M01AC06, ,
ATC
meloxicam; systemic, rectal
+∞
6.4
6
*
D06AX01, ,
ATC
fusidic acid; topical
+∞
6.4
6
*
J3010, ,
ICD-10 Finland
Allergic rhinitis due to pollen
+∞
6.4
6
*
L08, ,
ICD-O-3
+∞
6.4
6
*
TPH04, ,
ICD-O-3
+∞
6.4
6
*
A02BC05, ,
ATC
esomeprazole; systemic
+∞
6.4
6
*
L01, ,
ICD-O-3
+∞
6.4
6
*
R509, ,
ICD-10 Finland
Fever, unspecified
+∞
6.4
6
*
WZC30, ,
ICD-O-3
+∞
6.4
6
*
202, ,
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
+∞
6.4
6
*
SAA04, ,
ICD-O-3
+∞
6.4
6
*
LC2BE, ,
ICD-O-3
+∞
6.4
6
*
H29, ,
ICD-O-3
+∞
6.4
6
*
M796, ,
ICD-O-3
+∞
6.4
6
*
Z039, ,
ICD-10 Finland
Observation for suspected disease or condition, unspecified
+∞
6.4
6
*
Y25, ,
ICD-O-3
+∞
6.4
6
*
J01EA01, ,
ATC
trimethoprim; systemic
+∞
6.4
6
*
A97, ,
ICD-O-3
+∞
6.4
6
*
EB4VA, ,
ICD-O-3
+∞
6.4
6
*
OAA64, ,
ICD-O-3
+∞
6.4
6
*
K047, ,
ICD-O-3
+∞
6.4
6
*
R103, ,
ICD-O-3
+∞
6.4
6
*
F29, ,
ICD-O-3
+∞
6.4
6
*
E000001, ,
ATC
+∞
6.4
6
*
D07CA01, ,
ATC
hydrocortisone and antibiotics; topical
+∞
6.4
6
*
UDC00, ,
ICD-O-3
+∞
6.4
6
*
UJF32, ,
ICD-O-3
+∞
6.4
6
*
ZYC02, ,
ICD-O-3
+∞
6.4
6
*
Z001, ,
ICD-O-3
+∞
6.4
6
*
P06, ,
ICD-O-3
+∞
6.4
6
*
F329, ,
ICD-10 Finland
Depressive episode, unspecified
+∞
6.4
6
*
ZXA10, ,
ICD-O-3
+∞
6.4
6
*
M545, ,
ICD-O-3
+∞
6.4
6
*
SAD01, ,
ICD-O-3
+∞
6.4
6
*
WW200, ,
ICD-O-3
+∞
6.4
6
*
SGB30, ,
ICD-O-3
+∞
6.4
6
*
U01, ,
ICD-O-3
+∞
6.4
6
*
SPAT1254, ,
ICD-O-3
+∞
6.4
6
*
Z023, ,
ICD-O-3
+∞
6.4
6
*
D10AX03, ,
ATC
azelaic acid; topical
+∞
6.4
6
*
R03BA05, ,
ATC
fluticasone; inhalant
+∞
6.4
6
*
SPAT1317, ,
ICD-O-3
+∞
6.4
6
*
ZXA00, ,
ICD-O-3
+∞
6.4
6
*
SCA03, ,
ICD-O-3
+∞
6.4
6
*
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
19
82
3.10
3.43
2.5
3.0
10.60
12.43
ng/l
—
5
36
43
310
3.46
3.15
7.5
7.4
110.09
105.51
ml/min/173m2
0.89
31
245
5
6
9.06
2.81
5.8
2.2
—
—
—
0
0
19
99
2.46
2.29
2.4
2.9
48.89
60.36
u/l
0.88
19
92
7
20
3.88
2.14
3.6
3.6
—
—
—
0
0
24
146
2.22
1.99
5.9
2.8
0.00
0.00
estimate
—
5
38
20
114
2.24
1.93
6.0
2.7
—
—
—
0
0
24
149
2.15
1.87
6.0
2.9
0.00
0.00
estimate
—
5
36
5
12
4.49
1.87
13.8
5.7
43.62
61.51
%
—
5
12
14
72
2.30
1.69
6.6
3.3
0.00
0.03
estimate
—
5
34
8
32
2.77
1.68
3.5
9.9
104.38
104.91
mmol/l
—
8
32
23
147
2.03
1.61
7.6
3.9
0.00
0.00
estimate
—
5
36
17
98
2.10
1.56
8.8
2.8
—
—
—
0
0
21
135
1.94
1.42
2.7
3.3
—
—
—
0
0
5
17
3.14
1.39
4.4
5.1
1.62
2.05
%
—
5
17
5
18
2.96
1.31
18.0
10.8
1.83
1.12
mg/l
—
5
18
5
19
2.80
1.24
2.8
29.4
24.72
24.09
mmol/l
—
5
19
8
39
2.24
1.22
10.8
6.5
2.13
1.54
mmol/l
—
8
32
9
45
2.21
1.12
1.3
1.9
—
—
—
0
0
7
37
2.03
0.98
2.7
3.8
28.64
32.64
s
—
7
37
6
31
2.06
0.87
4.8
4.7
24.13
23.90
mmol/l
—
6
31
18
128
1.63
0.80
3.6
2.9
70.91
66.58
nmol/l
0.40
18
116
5
24
2.20
0.77
2.4
38.9
4.86
5.15
kpa
—
5
24
5
24
2.20
0.77
2.4
39.0
17.26
13.72
kpa
—
5
24
5
29
1.80
0.65
1.8
4.6
174.80
202.03
u/l
—
5
29
0
19
0.00
0.61
0.0
1.3
—
—
—
0
0
15
109
1.53
0.60
9.2
6.4
37.19
38.60
g/l
0.42
15
102
9
64
1.49
0.55
2.7
1.7
0.99
1.34
mmol/l
—
9
57
10
67
1.61
0.54
2.2
2.7
—
—
—
0
0
5
31
1.68
0.44
7.8
5.2
1.20
1.96
mmol/l
—
5
21
0
16
0.00
0.42
0.0
1.4
—
—
—
0
0
0
17
0.00
0.41
0.0
1.8
—
—
—
0
0
19
155
1.36
0.40
1.5
1.7
—
—
—
0
0
6
43
1.45
0.36
1.7
1.4
—
—
—
0
0
8
63
1.32
0.30
2.1
2.7
344.38
375.63
u/l
—
8
63
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
17
148
1.22
0.20
2.2
2.5
—
—
—
0
0
8
70
1.17
0.17
1.9
1.8
—
—
—
0
0
15
135
1.16
0.11
2.2
2.4
—
—
—
0
0
5
48
1.05
0.09
1.6
1.3
—
—
—
0
0
10
89
1.15
0.07
2.7
1.9
1.18
1.39
%
—
10
84
12
131
0.89
0.06
2.8
3.4
24.42
35.56
u/l
2.37
12
124
28
273
1.06
0.01
3.0
3.4
15.47
14.36
pmol/l
1.24
23
251
40
403
0.97
0.00
3.7
3.7
—
—
—
0
0
5
56
0.88
0.00
2.0
1.7
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
9
0.00
-0.00
0.0
3.4
—
96.11
—
0
9
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
97.67
—
0
6
0
9
0.00
-0.00
0.0
1.2
—
2.30
—
0
9
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
-0.00
0.0
2.6
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.3
—
130.00
—
0
8
0
5
0.00
-0.00
0.0
1.6
—
7.26
—
0
5
0
7
0.00
-0.00
0.0
58.0
—
24.43
—
0
7
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: Q17_PECTUS_CARINATUM – Pectus carinatum
GWS hits: -
This endpoint is excluded (different definition than used in FinnGen).